BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34551978)

  • 21. A Chimeric Pneumovirus Fusion Protein Carrying Neutralizing Epitopes of Both MPV and RSV.
    Wen X; Pickens J; Mousa JJ; Leser GP; Lamb RA; Crowe JE; Jardetzky TS
    PLoS One; 2016; 11(5):e0155917. PubMed ID: 27224013
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for immunization with postfusion respiratory syncytial virus fusion F glycoprotein (RSV F) to elicit high neutralizing antibody titers.
    Swanson KA; Settembre EC; Shaw CA; Dey AK; Rappuoli R; Mandl CW; Dormitzer PR; Carfi A
    Proc Natl Acad Sci U S A; 2011 Jun; 108(23):9619-24. PubMed ID: 21586636
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VLPs generated by the fusion of RSV-F or hMPV-F glycoprotein to HIV-Gag show improved immunogenicity and neutralizing response in mice.
    Trinité B; Durr E; Pons-Grífols A; O'Donnell G; Aguilar-Gurrieri C; Rodriguez S; Urrea V; Tarrés F; Mane J; Ortiz R; Rovirosa C; Carrillo J; Clotet B; Zhang L; Blanco J
    Vaccine; 2024 May; 42(15):3474-3485. PubMed ID: 38641492
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural basis for ultrapotent antibody-mediated neutralization of human metapneumovirus.
    Banerjee A; Huang J; Rush SA; Murray J; Gingerich AD; Royer F; Hsieh CL; Tripp RA; McLellan JS; Mousa JJ
    Proc Natl Acad Sci U S A; 2022 Jun; 119(25):e2203326119. PubMed ID: 35696580
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design and Evaluation of a Multi-Epitope Peptide of Human Metapneumovirus.
    Li X; Guo L; Kong M; Su X; Yang D; Zou M; Liu Y; Lu L
    Intervirology; 2015; 58(6):403-12. PubMed ID: 27096202
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potently neutralizing and protective anti-human metapneumovirus antibodies target diverse sites on the fusion glycoprotein.
    Rappazzo CG; Hsieh CL; Rush SA; Esterman ES; Delgado T; Geoghegan JC; Wec AZ; Sakharkar M; Más V; McLellan JS; Walker LM
    Immunity; 2022 Sep; 55(9):1710-1724.e8. PubMed ID: 35944529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identification of antibody neutralization epitopes on the fusion protein of human metapneumovirus.
    Ulbrandt ND; Ji H; Patel NK; Barnes AS; Wilson S; Kiener PA; Suzich J; McCarthy MP
    J Gen Virol; 2008 Dec; 89(Pt 12):3113-3118. PubMed ID: 19008400
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The two major human metapneumovirus genetic lineages are highly related antigenically, and the fusion (F) protein is a major contributor to this antigenic relatedness.
    Skiadopoulos MH; Biacchesi S; Buchholz UJ; Riggs JM; Surman SR; Amaro-Carambot E; McAuliffe JM; Elkins WR; St Claire M; Collins PL; Murphy BR
    J Virol; 2004 Jul; 78(13):6927-37. PubMed ID: 15194769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Profiling of hMPV F-specific antibodies isolated from human memory B cells.
    Xiao X; Fridman A; Zhang L; Pristatsky P; Durr E; Minnier M; Tang A; Cox KS; Wen Z; Moore R; Tian D; Galli JD; Cosmi S; Eddins MJ; Sullivan NL; Yan X; Bett AJ; Su HP; Vora KA; Chen Z; Zhang L
    Nat Commun; 2022 May; 13(1):2546. PubMed ID: 35538099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Development of a 3Mut-Apex-Stabilized Envelope Trimer That Expands HIV-1 Neutralization Breadth When Used To Boost Fusion Peptide-Directed Vaccine-Elicited Responses.
    Chuang GY; Lai YT; Boyington JC; Cheng C; Geng H; Narpala S; Rawi R; Schmidt SD; Tsybovsky Y; Verardi R; Xu K; Yang Y; Zhang B; Chambers M; Changela A; Corrigan AR; Kong R; Olia AS; Ou L; Sarfo EK; Wang S; Wu W; Doria-Rose NA; McDermott AB; Mascola JR; Kwong PD
    J Virol; 2020 Jun; 94(13):. PubMed ID: 32295908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Elicitation of pneumovirus-specific B cell responses by a prefusion-stabilized respiratory syncytial virus F subunit vaccine.
    Phung E; Chang LA; Mukhamedova M; Yang L; Nair D; Rush SA; Morabito KM; McLellan JS; Buchholz UJ; Mascola JR; Crank MC; Chen G; Graham BS; Ruckwardt TJ
    Sci Transl Med; 2022 Jun; 14(650):eabo5032. PubMed ID: 35731888
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neutralizing Antibodies Induced by First-Generation gp41-Stabilized HIV-1 Envelope Trimers and Nanoparticles.
    Kumar S; Lin X; Ngo T; Shapero B; Sou C; Allen JD; Copps J; Zhang L; Ozorowski G; He L; Crispin M; Ward AB; Wilson IA; Zhu J
    mBio; 2021 Jun; 12(3):e0042921. PubMed ID: 34156262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuated Human Parainfluenza Virus Type 1 Expressing the Respiratory Syncytial Virus (RSV) Fusion (F) Glycoprotein from an Added Gene: Effects of Prefusion Stabilization and Packaging of RSV F.
    Liu X; Liang B; Ngwuta J; Liu X; Surman S; Lingemann M; Kwong PD; Graham BS; Collins PL; Munir S
    J Virol; 2017 Nov; 91(22):. PubMed ID: 28835504
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Murine immune responses to virus-like particle-associated pre- and postfusion forms of the respiratory syncytial virus F protein.
    McGinnes Cullen L; Schmidt MR; Kenward SA; Woodland RT; Morrison TG
    J Virol; 2015 Jul; 89(13):6835-47. PubMed ID: 25903340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
    Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
    J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A neutralizing single-domain antibody that targets the trimer interface of the human metapneumovirus fusion protein.
    Ballegeer M; van Scherpenzeel RC; Delgado T; Iglesias-Caballero M; García Barreno B; Pandey S; Rush SA; Kolkman JA; Mas V; McLellan JS; Saelens X
    mBio; 2024 Jan; 15(1):e0212223. PubMed ID: 38117059
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of prefusion-F-specific antibodies elicited by natural infection with human metapneumovirus.
    Rush SA; Brar G; Hsieh CL; Chautard E; Rainho-Tomko JN; Slade CD; Bricault CA; Kume A; Kearns J; Groppo R; Mundle ST; Zhang L; Casimiro D; Fu TM; DiNapoli JM; McLellan JS
    Cell Rep; 2022 Sep; 40(12):111399. PubMed ID: 36130517
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crystal Structure and Immunogenicity of the DS-Cav1-Stabilized Fusion Glycoprotein From Respiratory Syncytial Virus Subtype B.
    Joyce MG; Bao A; Chen M; Georgiev IS; Ou L; Bylund T; Druz A; Kong WP; Peng D; Rundlet EJ; Van Galen JG; Wang S; Yang Y; Zhang B; Chuang GY; McLellan JS; Graham BS; Mascola JR; Kwong PD
    Pathog Immun; 2019; 4(2):294-323. PubMed ID: 31893251
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structure-Based Design of Head-Only Fusion Glycoprotein Immunogens for Respiratory Syncytial Virus.
    Boyington JC; Joyce MG; Sastry M; Stewart-Jones GB; Chen M; Kong WP; Ngwuta JO; Thomas PV; Tsybovsky Y; Yang Y; Zhang B; Chen L; Druz A; Georgiev IS; Ko K; Zhou T; Mascola JR; Graham BS; Kwong PD
    PLoS One; 2016; 11(7):e0159709. PubMed ID: 27463224
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant effect of the human metapneumovirus (HMPV) matrix protein in HMPV subunit vaccines.
    Aerts L; Rhéaume C; Carbonneau J; Lavigne S; Couture C; Hamelin MÈ; Boivin G
    J Gen Virol; 2015 Apr; 96(Pt 4):767-774. PubMed ID: 25519171
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.